Región del Biobío
Este organismo compró $36.063.373.892 en 19.068 órdenes de compra , sobre todo en Salud, servicios sanitarios y alimentación / Medicina y servicios de salud / Evaluaciones de salud individuales y le compró principalmente a Sofitec.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $2367,5 M |
| 2025 | $3863,6 M |
| 2024 | $3574,8 M |
| 2023 | $2943,5 M |
| 2022 | $2314,5 M |
| 2021 | $1928,6 M |
| 2020 | $1336,3 M |
| 2019 | $1234,4 M |
| 2018 | $1537,2 M |
| 2017 | $1332,5 M |
| 2016 | $1211,6 M |
| 2015 | $900,7 M |
| 2014 | $767,8 M |
| 2013 | $551,2 M |
| 2012 | $511,4 M |
| 2011 | $497,4 M |
| 2010 | $8341,6 M |
| 2009 | $374,2 M |
| 2008 | $225,2 M |
| 2007 | $211,6 M |
| 2006 | $38 M |
Gasto en remedios comprados fuera de CENABAST cada segundo semestre, y la proyección H2-2026 (estacional). En verde, el sobreprecio evitable si se comprara vía CENABAST (~27%, conservador).
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2102-303-SE26 | 22-04-2026 | Farmalatina Ltda. | Recepcion Conforme | $3.317.244 |
| 2102-301-SE26 | 22-04-2026 | Winkler Limitada | Recepcion Conforme | $366.282 |
| 2102-300-SE26 | 22-04-2026 | Valtek S.A. | Recepcion Conforme | $11.638.498 |
| 2102-305-SE26 | 22-04-2026 | Quorux Chile SpA | Enviada a proveedor | $34.272 |
| 2102-302-SE26 | 22-04-2026 | Medicatec de Chile S.A. | Recepcion Conforme | $1.085.042 |
| 2102-299-AG26 | 21-04-2026 | Jose Luis Pavez SpA | Aceptada | $4.998.000 |
| 2102-295-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $141.551 |
| 2102-292-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $2.840.042 |
| 2102-294-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $636.638 |
| 2102-289-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $601.188 |
| 2102-291-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $52.360 |
| 2102-290-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $2.007.352 |
| 2102-298-AG26 | 20-04-2026 | Doña Maite SpA | Recepcion Conforme | $5.917.275 |
| 2102-274-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $856.776 |
| 2102-285-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $104.696 |
| 2102-283-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $241.511 |
| 2102-282-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $663.080 |
| 2102-272-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $588.104 |
| 2102-270-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $890.037 |
| 2102-287-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $561.936 |
| 2102-284-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $47.588 |
| 2102-288-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $1.896.741 |
| 2102-277-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $232.514 |
| 2102-276-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $614.272 |
| 2102-278-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $639.286 |
| 2102-279-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $702.540 |
| 2102-286-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Aceptada | $89.214 |
| 2102-293-SE26 | 20-04-2026 | Jose Luis Pavez SpA | Recepcion Conforme | $800.834 |
| 2102-261-AG26 | 17-04-2026 | Farmaceutica Bioformula Limitada | Recepcion Conforme | $828.240 |
| 2102-273-AG26 | 17-04-2026 | Scm Pharma SpA | Recepcion Conforme | $358.871 |
